Hard to believe the FDA expanded the use of Celebrex, the same drug that can stop a patient's heart, to treat juvenile rheumatoid arthritis (RA) last week. Then again, maybe not, considering all the wrong-headed decisions the agency has made in recent years.
The decision comes on the heels of an advisory committee's recommendation late last month that Celebrex be approved as an effective -- but not safe -- alternative for juvenile RA and it allows Pfizer to market the harmful NSAID drug for young children, over age 2.
Makes one wonder when, not if, conventional medicine will discover Celebrex is just another drug as harmful and useless to RA patients, young and old alike, as Remicade or Humira.
The most effective treatment I've found for RA that has nothing at all to do with taking a dangerous drug: A revised protocol I've developed over the past 15 years that's based on the ground-breaking work done by health pioneer, Dr. Thomas Brown.
USA Today December 15, 2006